Time-pattern of adverse outcomes after an infection-triggered acute heart failure decompensation and the influence of early antibiotic administration and hospitalisation: results of the PAPRICA-3 study

Heart Failure

Factors associated with in-hospital mortality and adverse outcomes during the vulnerable post-discharge phase after the first episode of acute heart failure: results of the NOVICA-2 study

Clin Res Cardiol.

Rizzi MA, Sarasola AG, Arbé AA, Mateo SH, Gil V, Llorens P, Jacob J, Martín-Sánchez FJ, Puente PH, Escoda R, Espinosa B, Roset À, Torres-Gárate R, Torres-Murillo J, Mecina AB, López-Díez MP, Pérez JMÁ, Tost J, Salvo E, López-Grima ML, Gil C, Mir M, Rutzinska F, Chioncel O, Miró Ò, ICA-SEMES Research Group.

doi: 10.1007/s00392-020-01710-0.

Atrial FibrillationHeart, Artery and Coronary DiseasesHeart FailureHypertension

Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure

Clin Res Cardiol.

Llorens P, Javaloyes P, Martín-Sánchez FJ, Jacob J, Herrero-Puente P, Gil V, Garrido JM7, Salvo E, Fuentes M, Alonso H, Richard F, Lucas FJ, Bueno H, Parissis J, Müller CE, Miró Ò, ICA-SEMES Research Group

doi: 10.1007/s00392-018-1261-z.

Heart Failure

Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction

Heart.

Choi KH, Lee GY, Choi JO, Jeon ES, Lee HY, Cho HJ, Lee SE, Kim MS, Kim JJ, Hwang KK, Chae SC, Baek SH, Kang SM, Choi DJ, Yoo BS, Kim KH, Park HY, Cho MC, Oh BH

doi: 10.1136/

RECOMMENDED

Heart Failure

Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)

★ 2 Recommended by Prof. Dr Isabella Sudano, Faculty Member

Eur J Heart Fail.

Damman K, Beusekamp JC, Boorsma EM, Swart HP, Smilde TDJ, Elvan A, van Eck JWM, Heerspink HJL, Voors AA

doi: 10.1002/ejhf.1713.

Heart Failure

A Novel Rehabilitation Intervention for Older Patients With Acute Decompensated Heart Failure: The REHAB-HF Pilot Study

JACC Heart Fail.

Reeves GR, Whellan DJ, O'Connor CM, Duncan P, Eggebeen JD, Morgan TM, Hewston LA, Pastva A, Patel MJ, Kitzman DW

doi: 10.1016/j.jchf.2016.12.019.

Heart Failure

Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial

JACC Heart Fail.

Cerbin LP, Ambrosy AP, Greene SJ, Armstrong PW, Butler J, Coles A, DeVore AD, Ezekowitz JA, Hernandez AF, Metra M, Starling RC, Tang W, Teerlink JR, Voors AA, Wu A, O'Connor CM, Mentz RJ

doi: 10.1016/j.jchf.2018.01.018.

Heart Failure

Management of cardiogenic shock in acute decompensated chronic heart failure: The ALTSHOCK phase II clinical trial

Am Heart J.

Morici N, Oliva , Ajello S, Stucchi M, Sacco A, Cipriani MG, De Bonis M, Garascia A, Gagliardone MP, Melisurgo G, Russo CF, La Vecchia C, Frigerio M, Pappalardo F

doi: 10.1016/j.ahj.2018.07.009.

Heart Failure

Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study

Eur J Heart Fail.

Senni M, Wachter R, Witte KK, Straburzynska-Migaj E, Belohlavek J, Fonseca C, Mueller C, Lonn E, Chakrabarti A, Bao W, Noe A, Schwende H, Butylin D, Pascual-Figal D, TRANSITION Investigators.

doi: 10.1002/ejhf.1670.

Heart Failure

Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology

Eur J Heart Fail.

Harjola VP, Parissis J, Bauersachs J, Brunner-La Rocca HP, Bueno H, Čelutkienė J, Chioncel O, Coats AJS, Collins SP, de Boer RA, Filippatos G, Gayat E, Hill L, Laine M, Lassus J, Lommi J, Masip J, Mebazaa A, Metra M, Miró Ò, Mortara A, Mueller C, Mullens W, Peacock WF, Pentikäinen M, Piepoli MF, Polyzogopoulou E, Rudiger A, Ruschitzka F, Seferovic P, Sionis A, Teerlink JR, Thum T, Varpula M, Weinstein JM, Yilmaz MB

doi: 10.1002/ejhf.1831.

Related content

Factors associated with in-hospital mortality and adverse outcomes during the vulnerable post-discharge phase after the first episode of acute heart failure: results of the NOVICA-2 study

Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure

Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction

Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)

A Novel Rehabilitation Intervention for Older Patients With Acute Decompensated Heart Failure: The REHAB-HF Pilot Study

Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial

Management of cardiogenic shock in acute decompensated chronic heart failure: The ALTSHOCK phase II clinical trial

Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study

Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology